New role for the IMA in 2021

New roles

With the new Medicinal Products Act No. 100/2020 coming into
force the IMA has taken on new roles which are as follows:

  • to determine maximum price for prescription
    medicinal products both at wholesale and retail level
  • to determine maximum price for all veterinary
    medicinal products both at wholesale and retail level (both prescription and
    over the counter medicinal products)
  • to determine if a medicinal product falls under
    reimbursement and determine the reimbursement price
  • to determine if a medicinal product is qualifies
    as a Specialty care high-cost medinal product
  • to determine if an unlicensed medicinal product
    which is listed in the Named Patient Program (NPP) falls under reimbursement.

Inquiries on the aforementioned roles should be sent to [email protected].

Information dissemination

All communication concerning the aforementioned roles will
be performed by the IMA on or after 1st of January 2021.

Disclaimer
and copyright

Last updated: January 7, 2021
Var efnið hjálplegt Yes No

Hvað þarf að laga?


LiveChat